Food and Drug Administration (FDA) approved some GLP-1 medications, including semaglutide and liraglutide, for weight management in obese patients
No injection or needle required Usually requires daily adherence May have specific fasting or timing instructions Can produce gastrointestinal side effects Ongoing treatment may be needed to maintain benefits Wegovy Injection Prescription semaglutide administered under the skin once weekly according to a clinician-directed plan
If certain IRS conditions are met, HSAs and/or FSAs allow employees to use pre-tax dollars to pay for eligible prescription medications, and employers may opt to make contributions to such accounts, which employees can apply toward such costs
A 91/100 in Safety & Legitimacy, LegitScript certification, a clean disciplinary record, and a verifiable US address all mean the clinical fundamentals here are rock solid
However, some studies have reported neutral or negative mood effects, underscoring the need to understand individual variability
Our article on GLP-1 vs Natural Weight Loss explores this in depth